Which is better, HALO or LMAT?

On the Buffett-Fit framework, LeMaitre Vascular, Inc. (LMAT) currently grades higher than HALO — 77/100 (B grade) vs 79/100 (B). That said, "better" depends on which framework you trust — HALO wins on Warren Buffett, Charlie Munger, and Terry Smith; LMAT wins on Benjamin Graham, Philip Fisher, Peter Lynch, and Joel Greenblatt. The full pillar breakdown is on this page.

Should I buy HALO or LMAT?

This page is an educational comparison, not investment advice. Both HALO and LMAT are graded against the same Buffett 5-pillar framework (moat, earnings durability, management quality, financial health, valuation) plus six other documented investor frameworks. Read the side-by-side breakdown to see which one matches the criteria you care about most — and always do your own research before making any investment decision.

Is HALO better than LMAT for value investing?

The two are close on the headline Buffett-Fit score (79/100 vs 77/100), so "better for value investing" depends on which pillar you weight most. The five Buffett pillars + six other frameworks are broken down side-by-side on this page so you can pick the one that fits your style.

What's the difference between HALO and LMAT on Warren Buffett's framework?

Both stocks are evaluated on the same five pillars: economic moat (durable competitive advantage), earnings durability (consistent profitability), management quality (capital allocation), financial health (conservative balance sheet), and valuation (margin of safety). HALO currently scores 79/100 (B grade); LMAT scores 77/100 (B grade). The "Where each wins" section on this page breaks down which pillar each stock dominates.

Which has the stronger moat, HALO or LMAT?

Moat strength is one of the five pillars in the Buffett-Fit score on this page. HALO and LMAT are each scored on ROIC sustainability, gross-margin durability, and qualitative signals like brand strength, switching costs, network effects, and regulatory barriers. The pillar breakdown on this page shows the moat sub-score side-by-side so you can see which one has the more durable competitive advantage.

Which is more undervalued, HALO or LMAT?

Valuation is one of the five Buffett-Fit pillars on this page. Both stocks are scored on owner-earnings yield, price-to-intrinsic-value vs the underlying compounding rate, and the margin of safety relative to a conservative DCF. The valuation sub-score in the table below tells you which one currently trades at a more attractive price relative to its underlying business quality.

Are HALO and LMAT both Healthcare stocks?

Yes — both Halozyme Therapeutics, Inc. (HALO) and LeMaitre Vascular, Inc. (LMAT) operate in the Healthcare sector. That makes this a direct sector-peer comparison, which is the apples-to-apples way to use the Buffett-Fit framework: the score weighs each stock against its sector's specific quality and valuation benchmarks (sector-relative bonus), so the cross-stock comparison isn't distorted by inter-sector base-rate differences.

Is this HALO vs LMAT comparison investment advice?

No. This page is an educational pattern-match against documented public frameworks (Buffett, Graham, Fisher, Lynch, Greenblatt, Munger, Smith), not personalised investment advice. The scores reflect how closely each stock matches each framework's documented criteria — they are not buy/hold/sell recommendations. Always do your own research and consult a licensed financial adviser for personalised advice.

Stock comparison

Halozyme Therapeutics

HALO$8.1BHealthcare Market cap, Sector

LeMaitre Vascular

LMAT$2.23BHealthcare Market cap, Sector

Overall winner

LeMaitre Vascular

HALO 3 LMAT

Fit scores by strategy

HALO3wins

4winsLMAT

Warren Buffett

79B

B77

Benjamin Graham

83B

A89

Philip Fisher

65C

B81

Peter Lynch

53D

C67

Joel Greenblatt

40F

D56

Charlie Munger

80B

C68

Terry Smith

84B

C69

Side-by-side metrics

Metric	HALO	LMAT
Market cap	Winner: $8.1B	$2.23B
P/E (TTM)	Winner: 24.0x	37.1x
EV/EBIT	Winner: 10.2x	36.6x
ROIC (TTM)

Where each one wins

The metrics with the biggest gap between the two - sorted so the most decisive edges read first.

HALO leads on

Market cap$8.1Bvs $2.23B+72%
EV/EBIT10.2xvs 36.6x+72%
Revenue CAGR 5y33.23%vs 12.75%+62%
ROIC (TTM)23.65%vs 9.43%+60%

LMAT leads on

More like HALO

HALO vs PME.AX HALO vs CAMX.ST HALO vs BSLN.SW HALO vs 1681.HK

More like LMAT

LMAT vs PME.AX LMAT vs CAMX.ST

Related on invest-like

Strongest Moat Highest ROIC Warren Buffett strategy Economic Moat

Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.

Industries

Rankings

Glossary

Tools & Methodology

Halozyme Therapeutics

LeMaitre Vascular

Fit scores by strategy

Side-by-side metrics

Where each one wins

More like HALO

More like LMAT

Related on invest-like

Key terms in this analysis